⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research
prnewswire.com
MRK
PFE
BMY
JNJ
AZN
CGON
ASRT
Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize
prnewswire.com
TMO
AMGN
AGNC
BIO
QGEN
BIIB
GILD
REGN
BMY
MRK
SNY
LLY
ABBV
PFE
JNJ
AZN
BSX
MDLZ
GEHC
SYK
EW
ISRG
GOOG
MSFT
NVDA
AMAT
KLAC
LRCX
INTC
AMD
MU
WDC
SE
CRM
IBM
ORCL
SAP
ACN
GEN
PRG
EXAS
DXCM
ALGN
IDXX
VRTX
XRAY
CTAS
MDT
AMZN
GOOGL
CTSH
INFY
HPE
DELL
HPQ
LOGI
ADBE
CDNS
SNPS
MRVL
QCOM
NXPI
ON
ADI
TXN
MCHP
QRVO
NTAP
STX
WD
CRWD
PANW
FTNT
DDOG
SNOW
ETSY
ROKU
PYPL
MELI
JD
BABA
NTES
PDD
IQ
VIPS
NIO
LI
XPEV
RIVN
TSLA
GM
F
STLA
TM
VWAGY
HOG
Global Flow Cytometry Market to Reach USD 11.14 Billion by 2034 at 9% CAGR as Rising Adoption in Clinical Diagnostics, Growing Multiparameter Cell Analysis, and Advances in High-Parameter Flow Cytometry Accelerate Market Growth, Reports Maximize Market
prnewswire.com
TMO
BDX
DHR
AGNC
BIO
MRK
CYTK
Merck Manuals Details What Patients Need to Know About Inflammatory Bowel Disease
prnewswire.com
MRK
Single-Use Assemblies Market Set for Strong Growth as Biopharma Adoption Accelerates and USP 665 Standards Unlock New Opportunities
globenewswire.com
TMO
DHR
MRK
AVTR
GFF
RGEN
PH
3D Cell Culture Market Set for Strong Growth Through 2031, Fueled by Organoid Innovation, Drug Discovery and Personalized Medicine Demand
globenewswire.com
TMO
CRL
MRK
Microphysiological Systems Market Set for Strong Growth Through 2031, Fueled by Strategic Partnerships and Expanding Global Adoption
globenewswire.com
MRK
Cell Culture Supplements Market Set for Growth Through 2033, Fueled by Biopharma R&D, Biologics Production and Advanced Cell Therapies
globenewswire.com
TMO
DHR
GLW
REGN
AMGN
BMY
GILD
MRK
BNTX
RGEN
Capitalize on Breakthrough Therapy Designation Shifts: Benchmark Pfizer, Roche, Novartis, Merck and AstraZeneca to Accelerate Approvals, Defend Pipeline ROI and Capture Revenue
globenewswire.com
PFE
MRK
AZN
Engitix appoints Sonia Quaratino, MD, PhD as EVP Chief Medical Officer as its ECM pipeline moves toward clinical development
globenewswire.com
NVS
MRK